<font size=2 face="sans-serif"><b>BMJ Group collaborates with American
Diabetes Association to launch new title</b></font>
<br>
<br><font size=2 face="sans-serif"><i>Open access title to support medical
advances in the field through free, timely research</i></font>
<br>
<br><font size=2 face="sans-serif">International medical publisher, BMJ
Group, has teamed up with the American Diabetes Association to publish
an open access, online only journal.</font>
<br>
<br><font size=2 face="sans-serif">The new title, which will become the
official open access publication of the Association, will formally launch
in the Spring, as <b><i>BMJ Open Diabetes Research & Care</i></b><i>.</i></font>
<br>
<br><font size=2 face="sans-serif">Content will cover all aspects of basic
and clinical research in type 1 and type 2 diabetes, and associated complications.
All material will be subject to rigorous peer review. </font>
<br>
<br><font size=2 face="sans-serif">Open access is increasingly becoming
common practice in scholarship and research. This format will offer clinicians
and researchers free and rapid access to the latest original research on
the treatment and care of the disease, the prevalence of which has soared
in recent decades. </font>
<br>
<br><font size=2 face="sans-serif">In 2011, the numbers of people with
diabetes around the globe reached 366 million, according to data from the
International Diabetes Federation, and the World Health Organization estimates
that the annual death toll from the disease will increase by two thirds
between 2008 and 2030.</font>
<br>
<br><font size=2 face="sans-serif">Commenting on the announcement of the
new title, BMJ<i> </i>Group Publishing Director<i>, </i>Peter Ashman, said:
“The Association is leading the global fight against diabetes and we are
very proud that they have chosen to collaborate with the BMJ Group to launch
their latest official publication, which will be an important addition
to scientific and medical publishing.” </font>
<br>
<br><font size=2 face="sans-serif">“BMJ Group’s interest in improving
healthcare outcomes, and our mission to prevent and cure diabetes make
a perfect foundation for a new journal,” said Robert Ratner, Chief
Scientific & Medical Officer, American Diabetes Association.</font>
<br>
<br><font size=2 face="sans-serif"><b>Contact:</b></font>
<br><font size=2 face="sans-serif">BMJ Group PR Manager, Emma Dickinson,
</font>
<br><font size=2 face="sans-serif">Tel: +44 (0)207 383 6529</font>
<br><font size=2 face="sans-serif">Email: </font><a href=mailto:edickinson@bmjgroup.com><font size=2 color=blue face="sans-serif"><u>edickinson@bmjgroup.com</u></font></a>
<br>
<br><font size=2 face="sans-serif"><b>Notes for editors:</b></font>
<br><font size=2 face="sans-serif"><i>About BMJ Group</i></font>
<br><font size=2 face="sans-serif">BMJ Group is a global provider of trusted
and independent medical information and knowledge services for healthcare
professionals. For a full list of BMJ Group products, please click here:
</font><a href=http://group.bmj.com/products target=_blank><font size=2 color=blue face="sans-serif"><u>http://group.bmj.com/products</u></font></a>
<br>
<br><font size=2 face="sans-serif"><i>About the American Diabetes Association</i></font>
<br><font size=2 face="sans-serif"><i>Found in 1940, the American Diabetes
Association funds research to prevent, cure and manage diabetes, and among
its many activities delivers services to hundreds of communicates and advocates
on behalf of those affected by the disease. </i></font><a href=http://www.diabetes.org><font size=2 color=blue face="sans-serif"><i><u>www.diabetes.org</u></i></font></a>
<br>
<br>
<br><font size=2 face="Arial"><b>Stephanie Burns</b> </font><font size=3> </font>
<br><font size=2 face="Arial"><b>BMJ Group PR Executive</b> </font><font size=3> </font>
<br><font size=2 face="Arial"><b> </b> </font><font size=3> </font>
<br><font size=2 face="Arial">BMA House </font>
<br><font size=2 face="Arial">Tavistock Square </font>
<br><font size=2 face="Arial">London </font>
<br><font size=2 face="Arial">WC1H 9JR </font>
<br><font size=2 face="Arial"> </font>
<br><font size=2 face="Arial"><b>Tel: </b>+44 (0)207 383 6920 </font>
<br><font size=2 face="Arial"><b>Web: </b></font><a href=http://group.bmj.com/><font size=2 color=blue face="Arial"><u>http://group.bmj.com</u></font></a><font size=2 color=blue face="Arial">
</font><font size=3> </font>
<br><font size=2 face="Arial"><b>Twitter: </b></font><font size=2 color=blue face="Arial"><u>@BMJ_Group</u></font><font size=3>
</font>
<br><font size=3 color=blue> </font>
<br><font size=2 face="Arial">The BMJ Group Press Office is staffed <b>Monday
</b>to <b>Friday 9am </b>till <b>5pm</b></font><font size=3> </font>
<br><font size=2 face="Arial">For out of hours <b>urgent media enquiries
only</b> please call +44 (0)7825 118 107</font><font size=3> </font>
<br><br clear="both">
_______________________________________________________________________<BR>
The BMJ Group is one of the world's most trusted providers of medical information for doctors, researchers, health care workers and patients group.bmj.com. This email and any attachments are confidential. If you have received this email in error, please delete it and kindly notify us. If the email contains personal views then the BMJ Group accepts no responsibility for these statements. The recipient should check this email and attachments for viruses because the BMJ Group accepts no liability for any damage caused by viruses. Emails sent or received by the BMJ Group may be monitored for size, traffic, distribution and content. BMJ Publishing Group Limited trading as BMJ Group. A private limited company, registered in England and Wales under registration number 03102371. Registered office: BMA House, Tavistock Square, London WC1H 9JR, UK.<BR>
_______________________________________________________________________<BR>